X-85107621-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001367857.2(SATL1):c.1348G>C(p.Val450Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000826 in 1,211,181 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V450A) has been classified as Uncertain significance.
Frequency
Consequence
NM_001367857.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SATL1 | NM_001367857.2 | c.1348G>C | p.Val450Leu | missense_variant | Exon 3 of 8 | ENST00000644105.2 | NP_001354786.1 | |
SATL1 | NM_001367858.2 | c.1348G>C | p.Val450Leu | missense_variant | Exon 7 of 12 | NP_001354787.1 | ||
SATL1 | NM_001012980.2 | c.1348G>C | p.Val450Leu | missense_variant | Exon 1 of 5 | NP_001012998.2 | ||
SATL1 | XM_047442081.1 | c.1348G>C | p.Val450Leu | missense_variant | Exon 2 of 7 | XP_047298037.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000532 AC: 6AN: 112866Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 35014
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 183441Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67897
GnomAD4 exome AF: 0.00000364 AC: 4AN: 1098258Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 1AN XY: 363616
GnomAD4 genome AF: 0.0000531 AC: 6AN: 112923Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 35081
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1348G>C (p.V450L) alteration is located in exon 1 (coding exon 1) of the SATL1 gene. This alteration results from a G to C substitution at nucleotide position 1348, causing the valine (V) at amino acid position 450 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at